VF in the News

FDA Approves Label Update for Genentech’s Rituxan® (rituximab) in Granulomatosis with Polyangiitis and Microscopic Polyangiitis

October 19, 2018 — Genentech, a member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) has approved an update to the Rituxan® (rituximab) label to include information on follow up treatment of adult patients with Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) who…...

Read more

Early Diagnosis: A Key Challenge for Adult and Pediatric Patients, Core Theme of 2018 Annual Appeal

By Ed Becker One of the most important ways to potentially improve patients’ outcomes is also one of the biggest clinical challenges for doctors. Working to improve the rate of delays in vasculitis diagnosis is an area of keen interest to researchers, and it’s also the core theme of the…...

Read more

Artists Worldwide Paint 100 Portraits of Children With Rare Diseases, Now Being Widely Exhibited

By Catherine Lucas Any child illness is disruptive for a family, but having a child with a rare disease comes with its own set of challenges. Parents are faced with terrifying and obscure combinations of symptoms, and doctors are often just as mystified when it comes to diagnosing one of…...

Read more

From Five Contacts to 80 Today: VF Expands Area Contact Program

Shannon Morgan, VF Patient Coordinator   By Ed Becker The growth of the Vasculitis Foundation’s Area Contact Program tells you why it’s such an important part of the organization’s patient support services. Approximately 30 years ago, the Vasculitis Foundation created an international network of volunteers to be contacts for patients…...

Read more

Kidney Biopsies Help Predict End-Stage Disease in Older ANCA-Associated Vasculitis Patients

by Iqra Mumal A kidney biopsy is valuable in establishing a diagnosis and prognosis for end-stage renal disease in older patients with ANCA-associated vasculitis who have kidney involvement, although they are not useful for predicting overall survival, a study shows. “Prognosis and Histological Classification in Elderly Patients with ANCA-Glomerulonephritis: A…...

Read more